All posts by Administrator

Clinical Research Associate

By | Job Postings

Juno is seeking a highly motivated individual to join the Clinical Operations group. This individual will play a key role in assisting the Clinical Operations team in conduct of clinical trial activities, in accordance with all applicable regulations governing the conduct of clinical trials. The primary skills include logical thinking, ability to prioritize, “can-do” attitude, the ability to adapt quickly to changing business conditions, and demonstrate strong interpersonal and team building skills. Juno is looking for candidates that are able to recognize and synthesize information about the organizational climate and partner with key individuals to accomplish organizational goals.

Overall responsibilities include working closely with the assigned Study Manager to manage clinical operations activities in order to achieve trial objectives and corporate goals. This may require assistance in coordinating cross functional efforts in the administration and progress of a clinical trial(s). Work with clinical site staff during study startup and implementation, remote-based site CRAs to verify clinical data, data management on data cleaning activities, and specialty labs and imaging centers to monitor and coordinate activities, etc.

Apply for this position

  • Accepted file types: pdf, docx, doc.

Study Manager– Clinical Operations

By | Job Postings

Juno is seeking a highly motivated individual to join the Clinical Operations group. This individual will play a key role in assisting the Clinical Development team in the conduct of clinical trial activities, in accordance with all applicable regulations governing the conduct of clinical trials. The primary skills include logical thinking, ability to prioritize, “can-do” attitude, the ability to adapt quickly to changing business conditions, strong interpersonal and team building skills. Juno is looking for candidates that are able to recognize and synthesize information about the organizational climate and partner with key individuals to accomplish organizational goals. Overall responsibilities may include the management of clinical operations activities and coordinating cross functional efforts in the administration and progress of a clinical trial(s) in order to achieve trial objectives and corporate goals. The candidate will work with collaborating institutions to verify clinical data. The candidate will manage and support field-based monitoring staff to meet data review timelines.

Apply for this position

  • Accepted file types: pdf, docx, doc.

Clinical Trial Assistant

By | Job Postings

In accordance with ICH GCP guidelines and Juno SOPs, the Clinical Trial Assistant (CTA) will support the management of clinical trials and provide administrative support to the Juno Clinical Operations department. The CTA will possess strong communication skills, is highly competent in Microsoft Office Suite (including MS Word, Excel, PowerPoint with previous experience in SharePoint), and has experience working in a fast-paced environment within the biotech/pharmaceutical industry. The CTA will fulfill the following responsibilities

Apply for this position

  • Accepted file types: pdf, docx, doc.

JUNO APPOINTS JEFFREY BLUESTONE AS SCIENTIFIC ADVISOR

By | News, Press Release

SEATTLE (December 1, 2014) – Juno Therapeutics today announced the appointment of Jeffrey Bluestone, PhD, as scientific advisor. He will advise the company on T cell therapies, including potential applications in autoimmune disease and organ transplantation.

“We are delighted to have the opportunity to work with Dr. Bluestone, one of the world’s outstanding T cell biologists, who has made major contributions in basic immunology and in the translation of those discoveries to clinical trials,” said Juno CEO Hans Bishop.

Bluestone’s scientific work includes building a broad understanding of human immune responses at the molecular level, with significant contributions to stem cell research and immunology. He has published more than 400 peer-reviewed publications in journals including Nature, Nature Immunology, the Journal of Immunology, and Diabetes.

“I am excited to be working with Juno’s outstanding scientific founders and team to translate discoveries in immune tolerance into medical applications,” said Bluestone.

Bluestone is the A.W. and Mary Margaret Clausen Distinguished Professor and Director of the Hormone Research Institute at the University of California San Francisco, where he guides the institute’s autoimmunity research and clinical initiatives in immune tolerance and T cell therapies. He has held appointments at the University of Chicago and the National Cancer Institute, and is a member of the American Academy of Arts and Sciences and the Institute of Medicine. After earning his BS in biology and MS in microbiology from Rutgers University, Bluestone earned a PhD in immunology from the Cornell Graduate School of Medical Science.

###
About Juno

Juno Therapeutics, Inc. is building a fully integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body’s immune system to treat cancer. Founded on the vision that the use of human cells as therapeutic entities will drive one of the next important phases in medicine, Juno is developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as solid tumors. Several product candidates have shown compelling evidence of tumor shrinkage in the clinical trials in refractory leukemia and lymphoma conducted to date. The company’s long-term aim is to improve and leverage its cell-based platform to develop new product candidates that address a broader range of cancers and human diseases. Juno brings together innovative technologies from three of the world’s leading research institutions – the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, and Seattle Children’s Research Institute.

www.JunoTherapeutics.com

Contact:Morgan Warners, The Glover Park Group
mwarners@gpg.com, 202-295-0124

JUNO APPOINTS MAGGIE WILDEROTTER TO BOARD OF DIRECTORS

By | News, Press Release

SEATTLE (November 25, 2014) – Juno Therapeutics today announced that Maggie Wilderotter, Chairman and CEO of Frontier Communications Corporation, has been appointed to the Juno Board of Directors.

Wilderotter, the eighth member of Juno’s Board of Directors, brings significant public company experience as both a board member and a senior executive to the Juno Board. Before joining Frontier Communications in 2004, Wilderotter was Senior Vice President of Worldwide Public Sector at Microsoft. She has also held senior positions with Wink Communications, AT&T, and McCaw Cellular Communications. She serves on the boards of Xerox Corporation, Procter & Gamble Company, and a number of non-profit organizations.

“Maggie’s management acumen and distinguished Board service make her a widely respected adviser, and we are delighted she is bringing her wise counsel to Juno’s Board,” said Juno CEO Hans Bishop.

Among other accolades, from 2009 through 2013 Wilderotter was ranked by FORTUNE magazine as one of the “50 Most Powerful Women in Business” and the Financial Times in 2011 named Wilderotter one of “The Top 50 Women in World Business.”

“I look forward to working with Juno’s board and management team to build on the company’s successful first year. The scientific discovery Juno is engaged in combined with a first class strategy to bring forward game changing therapies makes this a company I am privileged to be associated with,” said Wilderotter.

Mrs. Wilderotter holds a bachelor’s degree in economics from the College of the Holy Cross and was awarded an Honorary Doctor of Engineering degree, honoris causa, from the Stevens Institute of Technology.

 

###

 

About Juno

 

Juno Therapeutics, Inc. is building a fully integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body’s immune system to treat cancer. Founded on the vision that the use of human cells as therapeutic entities will drive one of the next important phases in medicine, Juno is developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as solid tumors.  Several product candidates have shown compelling evidence of tumor shrinkage in the clinical trials in refractory leukemia and lymphoma conducted to date. The company’s long-term aim is to improve and leverage its cell-based platform to develop new product candidates that address a broader range of cancers and human diseases.  Juno brings together innovative technologies from three of the world’s leading research institutions – the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, and Seattle Children’s Research Institute.

 

www.JunoTherapeutics.com

 

Contact: Morgan Warners, The Glover Park Group 

mwarners@gpg.com, 202-295-0124

Senior Engineer

By | Job Postings

Juno is seeking a Senior Engineer to join the Manufacturing and Operations department. This position will be a key member of the team responsible for the design, construction, and qualification of a GMP cell therapy commercial manufacturing facility. The Senior Engineer will be the primary resource and subject matter expert for process and equipment design, process utilities, and process automation, with specific emphasis on optimization, start-up and commissioning, troubleshooting, and risk analysis.

Apply for this position

  • Accepted file types: pdf, docx, doc.

Senior Research Associate

By | Job Postings

The Senior Research Associate will assist scientists and engineers within the Process Development group to develop manufacturing processes for CAR and TCR products. This includes performing experiments in cell selection, T cell activation, gene delivery, and cell expansion. The Senior Research Associate should also be familiar with analytical techniques including flow cytometry, cell counting and spent medium analysis. The position will require data analysis, drafting technical reports and presentation of results.

Apply for this position

  • Accepted file types: pdf, docx, doc.

Platform Development Engineer

By | Job Postings

The Platform Development Engineer will participate in manufacturing technology development efforts, both internally and in collaboration with leading research institutions, delivering best-in-class manufacturing methods for autologous T-cell therapies. The manufacturing technology platform provides the basis for production of all of Juno’s cell therapy products and provides a framework for optimization of cost of goods and improved production capacity. The position will assist in process development efforts for CARs and TCRs by providing process simulation, cost modeling, and execution of experiments.

Apply for this position

  • Accepted file types: pdf, docx, doc.